Cargando…

Microbiome in Hidradenitis Suppurativa—What We Know and Where We Are Heading

Recently, interest in the microbiome of cutaneous diseases has increased tremendously. Of particular interest is the gut-brain-skin axis proposed by Stokes and Pillsbury in 1930. The microbiome has been suggested in the pathogenesis of hidradenitis suppurativa, however the link between the commensal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Świerczewska, Zuzanna, Lewandowski, Miłosz, Surowiecka, Agnieszka, Barańska-Rybak, Wioletta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570026/ https://www.ncbi.nlm.nih.gov/pubmed/36232581 http://dx.doi.org/10.3390/ijms231911280

Ejemplares similares

Immunomodulatory Drugs in the Treatment of Hidradenitis Suppurativa—Possibilities and Limitations
por: Świerczewska, Zuzanna, et al.
Publicado: (2022)

Could a handbook serve as a useful educational intervention in improving disease knowledge? A cross-sectional study among patients with hidradenitis suppurativa in Poland
por: Lewandowski, Miłosz, et al.
Publicado: (2022)

Hidradenitis Suppurativa: Where We Are and Where We Are Going
por: Scala, Emanuele, et al.
Publicado: (2021)

Off-Label Use of Botulinum Toxin in Dermatology—Current State of the Art
por: Lewandowski, Miłosz, et al.
Publicado: (2022)

Are YouTube videos a reliable source of information about body dysmorphic disorder?
por: Dobosz, Maria, et al.
Publicado: (2023)

Microbiome in Multiple Sclerosis: Where Are We, What We Know and Do Not Know
por: Boziki, Marina Kleopatra, et al.
Publicado: (2020)

Vestibular Schwannoma: What We Know and Where We are Heading
por: Gupta, Vinay Kumar, et al.
Publicado: (2020)

Single Virus Targeting Multiple Organs: What We Know and Where We Are Heading?
por: Prasad, Ashish, et al.
Publicado: (2020)

Teledermatology in the management of hidradenitis suppurativa: Should we improve this service?
por: Ruggiero, Angelo, et al.
Publicado: (2022)

2019 Novel coronavirus: where we are and what we know
por: Cheng, Zhangkai J., et al.
Publicado: (2020)

Pregnant adolescents living with HIV: what we know, what we need to know, where we need to go
por: Callahan, Tegan, et al.
Publicado: (2017)

The Microbiome in Hidradenitis Suppurativa: A Review
por: Wark, Kirsty J. L., et al.
Publicado: (2020)

Multidisciplinary Treatment in Toxic Epidermal Necrolysis
por: Surowiecka, Agnieszka, et al.
Publicado: (2023)

Correction to: 2019 Novel coronavirus: where we are and what we know
por: Cheng, Zhangkai J., et al.
Publicado: (2020)

Correction: 2019 Novel coronavirus: where we are and what we know
por: Cheng, Zhangkai J., et al.
Publicado: (2022)

Correction: 2019 Novel coronavirus: where we are and what we know
por: Cheng, Zhangkai J., et al.
Publicado: (2023)

Home sharing in marketing and tourism at a tipping point: What do we know, how do we know, and where should we be heading?
por: Lim, Weng Marc, et al.
Publicado: (2021)

Resistance in tuberculosis: what do we know and where can we go?
por: Green, Keith D., et al.
Publicado: (2013)

Hearing Loss and Cognition: What We Know and Where We Need to Go
por: Powell, Danielle S., et al.
Publicado: (2022)

Bacterial-Based Methods for Cancer Treatment: What We Know and Where We Are
por: Rommasi, Foad
Publicado: (2021)

Impulsive dispositions and alcohol: what we know, how we know it, and where to go from here
por: Stevens, Angela K., et al.
Publicado: (2018)

The origin of life: what we know, what we can know and what we will never know
por: Pross, Addy, et al.
Publicado: (2013)

Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023)

Maternal sleep position: what do we know where do we go?
por: O’Brien, Louise M, et al.
Publicado: (2015)

Parasite responses to pollution: what we know and where we go in ‘Environmental Parasitology’
por: Sures, Bernd, et al.
Publicado: (2017)

Understanding of type 1 diabetes mellitus: what we know and where we go
por: Cheon, Chong Kun
Publicado: (2018)

Coffee and digestive cancers—what do we know, and where do we go?
por: Loftfield, Erikka, et al.
Publicado: (2020)

COVID-19 and cardiovascular disease: What we know, what we think we know, and what we need to know
por: Dhawan, Rahul, et al.
Publicado: (2020)

The Composition of Subgingival Microbiome in Hidradenitis Suppurativa and Periodontitis Patients
por: Jastrząb, Beata, et al.
Publicado: (2023)

Quasicrystals: What do we know? What do we want to know? What can we know?
por: Steurer, Walter
Publicado: (2018)

International Trade and Investment and Food Systems: What We Know, What We Don’t Know, and What We Don’t Know We Don’t Know
por: Schram, Ashley, et al.
Publicado: (2020)

Animal Sentience: Where are We and Where are We Heading?
por: Proctor, Helen
Publicado: (2012)

Research Integrity: Where We Are and Where We Are Heading
por: Zhaksylyk, Alikhan, et al.
Publicado: (2023)

Minimally Invasive Glaucoma Surgery: What Do We Know? Where Should We Go?
por: Xin, Chen, et al.
Publicado: (2020)

Estrogen Formation and Inactivation Following TBI: What we Know and Where we Could go
por: Duncan, Kelli A.
Publicado: (2020)

The Essential Thrombocythemia in 2020: What We Know and Where We Still Have to Dig Deep
por: Accurso, Vincenzo, et al.
Publicado: (2020)

Therapeutic Strategies and Chemoprevention of Atherosclerosis: What Do We Know and Where Do We Go?
por: Aprotosoaie, Ana Clara, et al.
Publicado: (2022)

A Decade of College Student Hunger: What We Know and Where We Need to Go
por: Hagedorn-Hatfield, Rebecca L., et al.
Publicado: (2022)

Intraoperative Brain Mapping in Multilingual Patients: What Do We Know and Where Are We Going?
por: Martín-Fernández, Jesús, et al.
Publicado: (2022)

Canine and feline P‐glycoprotein deficiency: What we know and where we need to go
por: Mealey, Katrina L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ffhmts969jsqmkgmj0hs3h9al6